Coral Laboratories Limited

Rentabilité sur six mois: -12.79%
Rendement en dividendes: 0.23%

680.2 ₹

+70.45 ₹ +11.55%
589.5 ₹
993.45 ₹

paper.min_max_per_year

Calendrier des promotions Coral Laboratories Limited

À propos de l'entreprise Coral Laboratories Limited

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethopia, and internationally. The company offers antibiotics/antibacterial products, including antifungal, antiemetic, analgesics/antipyretic/antiinflammatory, antispasmodic, anticold, antiallergic, antiasthmatic, antidiabetic, antiemetics, anthelmentic, thyroid, and antiprotozoal/antiamebic products; antimalarial drugs, antipsychotic drugs, gastro-intestinal drugs, kits, muscle relaxants, cough suppressant/expectorant products, cardiovascular medicines, oral antiseptic preparations, mouthwashes, calcium preparations, and appetizers; and nutritional, protein, and iron supplements, as well as other products. It also provides cephalosporin, beta lactam, and lyophilized injectable products; eye/ear/nose drops; nasal sprays and metered dose inhales; and large volume parenteral products. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/phytochemicals, multivitamins, and nutrients, as well as OTC products. It provides its products in various dosage forms, including tablets, capsules, low RH facilities, liquid orals, liquids and powders, dry syrups, drops, ointment and creams, gels and lotions, granules powders, injectables, nasal sprays, and suppositories. Coral Laboratories Limited was incorporated in 1994 and is headquartered in Mumbai, India.

Paramètres de base

Industry
Pharmaceuticals
Sector
Health Care
Валюта
inr
Валюта отчета
inr
Див.доход ао
0.23
Дивиденд ао
2
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 1.72 8
P/BV 0.7979 9
P/E 8.97 9
Efficacité
Nom Signification Grade
ROA 8.31 3
ROE 9.5 3
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0.23 0.58
DSI 0.9286 9.29
Croissance moyenne du dividende 0.2778 0.46
Devoir
Nom Signification Grade
Debt/EBITDA 0 10
Debt/Ratio 0 10
Debt/Equity 0.1588 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % 16.32 3
Rentabilité Ebitda, % 0 5
Rentabilité EPS, % 121.44 10

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 609.75 ₹ 0 ₹ 0 ₹ +11.55 % 0 % 0 %
common.calendar.number_days.7d 595.65 ₹ 0 ₹ 0 ₹ +14.19 % 0 % 0 %
common.calendar.number_days.30d 769.05 ₹ 0 ₹ 0 ₹ -11.55 % 0 % 0 %
common.calendar.number_days.90d 630.2 ₹ 589.5 ₹ 777.2 ₹ +7.93 % 0 % 0 %
common.calendar.number_days.180d 780 ₹ 589.5 ₹ 808.65 ₹ -12.79 % 0 % 0 %
common.calendar.number_days.1y 924 ₹ 589.5 ₹ 993.45 ₹ -26.39 % 0 % 0 %
common.calendar.number_days.3y 241.5 ₹ 220 ₹ 993.45 ₹ +181.66 % 0 % 0 %
common.calendar.number_days.5y 190.2 ₹ 206.3 ₹ 993.45 ₹ +257.62 % 0 % 0 %
common.calendar.number_days.10y 92.45 ₹ 92.45 ₹ 1 134.2 ₹ +649.11 % 0 % 0 %
common.calendar.number_days.ytd 754.8 ₹ 589.5 ₹ 813.85 ₹ -9.88 % 0 % 0 %

Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Mr. Girish Madanlal Dhameja Whole-Time Director 1981 (44 année)
Ms. Sushma Shashi Kadkade CFO & Non-Exec. Director 1976 (49 années)
Ms. Ruchi Anjaria Company Sec. & Compliance Officer
Mr. Kapil K. Shah Exec. Officer

Informations sur l'entreprise

Adresse: India, Mumbai, #3B Patanwala Industrial Estate - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: http://corallab.com